The Northeast Valley Health Corp. in Los Angeles County could be a poster child for the benefits of sharing health data electronically. Through a data network connecting its records system with other providers, the health center receives not just X-ray and lab results but real-time alerts when hospitals on the network admit or discharge its…
by EMMA PAYNE Grief is expensive. In addition to the significant human impacts, research shows that bereavement leads to a 20%-30% increase in health care utilization. Grief is also common. While we may not like to talk about it, 37% of Americans are grieving a recent death. The U.S. averaged 3.26 million deaths per year…
Ann Bauer, a researcher who studies Tylenol and autism, felt queasy with anxiety in the weeks leading up to the White House’s much-anticipated autism announcement. In August, Bauer and her colleagues published an analysis of 46 previous studies on Tylenol, autism, and attention-deficit/hyperactivity disorder. Many found no link between the drug and the conditions, while…
AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data. The post AI Hallucinations: What Are They and Are They Always Bad? appeared first on MedCity News.
Pfizer is acquiring Metsera and its pipeline of obesity medications that could offer dosing and tolerability advantages for patients as well as a manufacturing edge for the pharma giant. Key data Phase 2 readouts for Metsera’s lead GLP-1 drug candidate are expected in 2026. The post Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major…
Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient. The post Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts appeared first on MedCity News.
Among the estimated 8 million people with intellectual and developmental disabilities (I/DD), over three million have Medicaid coverage.
With employee anxiety at an all-time high, reducing fear and stress is increasingly important to organizational performance. While leaders cannot control external events, they can help mitigate their impacts on their organizations and people. The post Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line appeared first on MedCity News.
This issue brief describes the impact of H.R.1’s 10-year delay in implementing provisions in two Medicaid eligibility rules that would have reduced red tape. The delayed rules are projected to decrease federal spending and future Medicaid and CHIP enrollment and increase coverage loss.
Ann Bauer, una investigadora que estudia la relación entre el Tylenol y el autismo, se sintió mareada de la ansiedad en las semanas previas al tan anticipado anuncio sobre autismo de la Casa Blanca. En agosto, Bauer y sus colegas publicaron un análisis de 46 estudios previos sobre Tylenol, autismo y trastorno por déficit de…